Galmed Pharmaceuticals Lt... (GLMD)
1.89
-0.07 (-3.57%)
At close: Mar 04, 2025, 9:58 AM
Galmed Pharmaceuticals Ltd. Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -6.91M | -17.87M | -32.47M | -28.77M | -20.46M | -9.86M | -12.3M | -16.95M | -10.62M | -9.1M | -17.48M | -3.15M |
| Depreciation & Amortization | 31K | 35K | 42K | 39K | 35K | 387K | 239K | 169K | 50K | 9K | 4K | 5K |
| Stock-Based Compensation | 892K | 1.3M | 1.89M | 2.07M | 2.23M | 1.78M | 1.39M | 1.63M | 970K | 601K | 10.85M | 208K |
| Other Working Capital | 468K | -140K | -275K | 54K | -750K | -538K | -1.35M | 1.71M | -223K | -28K | 38K | 60K |
| Other Non-Cash Items | -280K | 485K | 13K | -285K | -63K | -144K | -167K | 1.67M | 1.06M | 601K | 2.89M | 208K |
| Deferred Income Tax | n/a | n/a | 84K | -437K | -114K | 12K | 164K | -1.4M | -920K | -601K | n/a | -208K |
| Change in Working Capital | 132K | -2.45M | -2.45M | 1.1M | 3.44M | -1.21M | -1.4M | 2.75M | 986K | -748K | 1.22M | -143K |
| Operating Cash Flow | -6.14M | -18.5M | -32.89M | -26.29M | -14.94M | -9.02M | -12.07M | -12.13M | -8.47M | -9.24M | -2.52M | -3.08M |
| Capital Expenditures | n/a | -4K | -11K | -44K | -12K | -90K | -21K | -17K | -159K | -770K | -13K | -32K |
| Acquisitions | -1.5M | -17.57K | n/a | -24.94M | 21.8M | 6.08M | n/a | 13K | -6M | 8.25M | n/a | n/a |
| Purchase of Investments | -6.33M | -3.87M | -13.57M | -55.03M | -94.41M | -98.35M | -3.87M | -7.62M | -26.54M | -8.25M | n/a | n/a |
| Sales Maturities Of Investments | 8.63M | 21.44M | 25.04M | 71.61M | 101.1M | 38.42M | 10.32M | 13.96M | 15.59M | -2.25M | n/a | n/a |
| Other Investing Acitivies | n/a | 17.57K | -1K | 24.94M | -21.8M | -6.08M | 9K | 13K | 6M | -6M | 16K | n/a |
| Investing Cash Flow | 800K | 17.56M | 11.46M | 16.54M | 6.68M | -60.02M | 6.44M | 6.34M | -11.11M | -9.02M | 3K | -32K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.82M | 20K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | n/a | 61K | 143K | 1.03M | 530K | 255K | n/a | n/a | n/a | 3.66M |
| Financial Cash Flow | 6.18M | 70K | 17.37M | 768K | 143K | 80.18M | 15.55M | 4.73M | n/a | 41.86M | 1.94M | 3.68M |
| Net Cash Flow | 848K | -868K | -4.06M | -8.98M | -8.12M | 11.14M | 9.92M | -1.06M | -19.58M | 23.6M | -581K | 572K |
| Free Cash Flow | -6.14M | -18.5M | -32.9M | -26.33M | -14.95M | -9.11M | -12.09M | -12.15M | -8.63M | -10.01M | -2.54M | -3.11M |